Caribou Biosciences, Inc. (CRBU)
NASDAQ: CRBU · Real-Time Price · USD
1.700
-0.020 (-1.16%)
At close: Dec 26, 2025, 4:00 PM EST
1.690
-0.010 (-0.59%)
After-hours: Dec 26, 2025, 7:41 PM EST
Caribou Biosciences Market Cap
Caribou Biosciences has a market cap or net worth of $158.9 million as of December 26, 2025. Its market cap has decreased by -13.56% in one year.
Market Cap
158.90M
Enterprise Value
25.15M
1-Year Change
-13.56%
Ranking
Category
Stock Price
$1.70
Market Cap Chart
Since the IPO on July 23, 2021, Caribou Biosciences's market cap has decreased from $888.48M to $158.90M, a decrease of -82.12%. That is a compound annual growth rate of -32.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 26, 2025 | 158.90M | 10.36% |
| Dec 31, 2024 | 143.98M | -71.59% |
| Dec 29, 2023 | 506.71M | 32.27% |
| Dec 30, 2022 | 383.09M | -57.82% |
| Dec 31, 2021 | 908.30M | 2.23% |
| Jul 23, 2021 | 888.48M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 964.31B |
| Johnson & Johnson | 500.60B |
| AbbVie | 406.30B |
| UnitedHealth Group | 296.73B |
| AstraZeneca | 286.29B |
| Novartis AG | 267.64B |
| Merck & Co. | 264.21B |
| Novo Nordisk | 232.28B |